206A.T

Aug 14, 2026, 07:00 UTC

PRISM BioLab announced its financial results for the third quarter of fiscal year ending September 2026, reporting a net loss of 840 million yen for the cumulative nine months (October 2025-June 2026), widening from an 800 million yen loss a year earlier, while the April-June quarter net loss narrowed to 240 million yen from 320 million yen.